Evidence map›Paper›PMID 38866815›Full record

ArticleScientific reports2024

Investigating the potential of X chromosome shredding for mouse genetic biocontrol.

Mark D Bunting, Gelshan I Godahewa, Nicole O McPherson, Louise J Robertson, Luke Gierus, Sandra G Piltz, Owain Edwards, Mark Tizard, Paul Q Thomas

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Y-linked editors for invasive rodent control.Molecular biology and evolution · 2026
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mark D BuntingSchool of Biomedicine and Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
Gelshan I GodahewaSchool of Biomedicine and Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
Nicole O McPhersonSchool of Biomedicine and Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
Louise J RobertsonSchool of Biomedicine and Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
Luke GierusSchool of Biomedicine and Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
Sandra G PiltzSchool of Biomedicine and Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
Owain EdwardsCSIRO Environment, Floreat, WA, 6014, Australia.
Mark TizardAustralian Centre for Disease Preparedness, CSIRO Health and Biosecurity, Geelong, VIC, 3220, Australia.
Paul Q ThomasSchool of Biomedicine and Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia. paul.thomas@adelaide.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CRISPR-Cas9 technology has facilitated development of strategies that can potentially provide more humane and effective methods to control invasive vertebrate species, such as mice. One promising strategy is X chromosome shredding which aims to bias offspring towards males, resulting in a gradual and unsustainable decline of females. This method has been explored in insects with encouraging results. Here, we investigated this strategy in Mus musculus by targeting repeat DNA sequences on the X chromosome with the aim of inducing sufficient DNA damage to specifically eliminate X chromosome-bearing sperm during gametogenesis. We tested three different guide RNAs (gRNAs) targeting different repeats on the X chromosome, together with three male germline-specific promoters for inducing Cas9 expression at different stages of spermatogenesis. A modest bias towards mature Y-bearing sperm was detected in some transgenic males, although this did not translate into significant male-biasing of offspring. Instead, cleavage of the X chromosome during meiosis typically resulted in a spermatogenic block, manifest as small testes volume, empty tubules, low sperm concentration, and sub/infertility. Our study highlights the importance of controlling the timing of CRISPR-Cas9 activity during mammalian spermatogenesis and the sensitivity of spermatocytes to X chromosome disruption.

Indexed as

CRISPR-Cas SystemsSpermatogenesisX ChromosomeAnimalsFemaleMaleMeiosisMiceMice, TransgenicRNA, Guide, CRISPR-Cas SystemsSpermatozoaRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID38866815
PMCPMC11169450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.